Novo Nordisk A/S (NVO) Social Stream
Novo Nordisk A S (NVO) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering NVO.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 23 | $86.86 | $52.6 | $72.51 | $100.87 | -28.12% |
The Trend in the Analyst Price Target
NVO's average price target has moved up $1.71 over the prior 98 days.
NVO reports an average of 7.43% for its upside potential over the past 174 days.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2020-11-26 | 23 | 86.86 | 52.60 | 72.51 | 66.14 | 9.63% |
| 2020-11-18 | 23 | 86.86 | 52.60 | 72.50 | 66.52 | 8.99% |
| 2020-11-11 | 23 | 86.86 | 52.39 | 72.31 | 67.70 | 6.81% |
| 2020-10-30 | 21 | 86.52 | 51.63 | 72.39 | 63.89 | 13.3% |
| 2020-10-05 | 22 | 83.46 | 52.27 | 71.39 | 70.12 | 1.81% |
| 2020-09-26 | 21 | 83.46 | 52.27 | 71.85 | 69.06 | 4.04% |
| 2020-09-18 | 23 | 83.46 | 52.27 | 72.31 | NA | NA% |
| 2020-09-05 | 24 | 83.46 | 46.43 | 70.96 | NA | NA% |
| 2020-08-27 | 24 | 83.46 | 46.43 | 70.88 | NA | NA% |
| 2020-08-20 | 25 | 83.46 | 46.43 | 70.80 | NA | NA% |
| 2020-08-12 | 25 | 83.46 | 46.43 | 70.82 | NA | NA% |
| 2020-08-07 | 25 | 83.46 | 46.43 | 70.60 | NA | NA% |
| 2020-07-23 | 25 | 82.76 | 46.43 | 68.90 | NA | NA% |
| 2020-07-16 | 25 | 82.76 | 46.43 | 68.62 | NA | NA% |
| 2020-07-09 | 25 | 82.76 | 45.61 | 68.02 | NA | NA% |
| 2020-07-02 | 25 | 82.76 | 45.61 | 67.76 | NA | NA% |
| 2020-06-25 | 25 | 82.76 | 45.61 | 67.43 | NA | NA% |
| 2020-06-20 | 25 | 82.76 | 45.61 | 67.37 | NA | NA% |
| 2020-06-11 | 24 | 79.65 | 45.61 | 66.60 | NA | NA% |
| 2020-06-05 | 24 | 79.65 | 45.61 | 66.28 | NA | NA% |
NVO Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|
The Trend in the Broker Recommendations
NVO's average broker recommendation rating improved by 0.04 over the prior 31 days.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for NVO as an investment opportunity.
- Novo Nordisk A S's number of analysts covering the stock is higher than 99.58% of Pharmaceutical Products stocks.
- Novo Nordisk A S's upside potential (average analyst target price relative to current price) is higher than 1.64% of stocks in the mega market cap category.
- The average analyst price target of NVO is greater than 87.83% of Pharmaceutical Products stocks.
- Novo Nordisk A S's variance in analysts' estimates is less than 26.53% of all US stocks.
What is the outlook for NVO? Use POWR Ratings for clearer insight into price direction.